AAAAAA
Results:
1-12
|
Results: 12
Authors:
MOURITS MJE
HOLLEMA H
WILLEMSE PHB
DEVRIES EGE
AALDERS JG
VANDERZEE AGJ
Citation: Mje. Mourits et al., ADENOSARCOMA OF THE UTERUS FOLLOWING TAMOXIFEN TREATMENT FOR BREAST-CANCER, International journal of gynecological cancer, 8(2), 1998, pp. 168-171
Authors:
DEHULLU JA
DOTING E
PIERS D
HOLLEMA H
AALDERS JG
KOOPS HS
BOONSTRA H
VANDERZEE AGJ
Citation: Ja. Dehullu et al., SENTINEL LYMPH-NODE IDENTIFICATION WITH TC-99M-LABELED NANOCOLLOID INSQUAMOUS-CELL CANCER OF THE VULVA, The Journal of nuclear medicine, 39(8), 1998, pp. 1381-1385
Authors:
DEBRUIJN HWA
VANDERZEE AGJ
AALDERS JG
Citation: Hwa. Debruijn et al., THE VALUE OF CANCER ANTIGEN-125 (CA-125) DURING TREATMENT AND FOLLOW-UP OF PATIENTS WITH OVARIAN-CANCER, Current opinion in obstetrics & gynecology, 9(1), 1997, pp. 8-13
Authors:
PRAS E
WILLEMSE PHB
BOONSTRA H
HOLLEMA H
HEESTERS MAAM
SZABO BG
DEBRUIJN HWA
AALDERS JG
DEVRIES EGE
Citation: E. Pras et al., CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED-CARCINOMA OF THE CERVIX, Annals of oncology, 7(5), 1996, pp. 511-516
Authors:
DUK JM
GROENIER KH
DEBRUIJN HWA
HOLLEMA H
TENHOOR KA
VANDERZEE AGJ
AALDERS JG
Citation: Jm. Duk et al., PRETREATMENT SERUM SQUAMOUS-CELL CARCINOMA ANTIGEN - A NEWLY IDENTIFIED PROGNOSTIC FACTOR IN EARLY-STAGE CERVICAL-CARCINOMA, Journal of clinical oncology, 14(1), 1996, pp. 111-118
Authors:
VELDHUIS GJ
WILLEMSE PHB
VANDERGRAAF WTA
AALDERS JG
GROENEWEGEN A
DEVRIES EGE
Citation: Gj. Veldhuis et al., RHIL-3 AND G-CSF VS G-CSF ALONE AFTER TAXOL-IFOSFAMIDE-CISPLATIN (TIC) CHEMOTHERAPY (CT) IN RESIDUAL PROGRESSIVE OVARIAN-CANCER (OC), European journal of cancer, 31A, 1995, pp. 516-516
Authors:
VELDHUIS GJ
WILLEMSE PHB
VANGAMEREN MM
AALDERS JG
MULDER NH
MULL B
BIESMA B
DEVRIES EGE
Citation: Gj. Veldhuis et al., RECOMBINANT HUMAN INTERLEUKIN-3 TO DOSE-INTENSIFY CARBOPLATIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN EPITHELIAL OVARIAN-CANCER - A PHASE-I TRIAL, Journal of clinical oncology, 13(3), 1995, pp. 733-740
Authors:
VANDERZEE AGJ
HOLLEMA H
SUURMEIJER AJH
KRANS M
SLUITER WJ
WILLEMSE PHB
AALDERS JG
DEVRIES EGE
Citation: Agj. Vanderzee et al., VALUE OF P-GLYCOPROTEIN, GLUTATHIONE-S-TRANSFERASE-PI, C-ERBB-2, AND P53 AS PROGNOSTIC FACTORS IN OVARIAN CARCINOMAS, Journal of clinical oncology, 13(1), 1995, pp. 70-78
Authors:
VANDERZEE AGJ
HOLLEMA HH
DEBRUIJN HWA
WILLEMSE PHB
BOONSTRA H
MULDER NH
AALDERS JG
DEVRIES EGE
Citation: Agj. Vanderzee et al., CELL BIOLOGICAL MARKERS OF DRUG-RESISTANCE IN OVARIAN-CARCINOMA, Gynecologic oncology, 58(2), 1995, pp. 165-178
Authors:
VEENHOF CHN
VANDERBURG MEL
NOOY M
AALDERS JG
PECORELLI S
OLIVEIRA CF
ROTMENSZ N
VERMORKEN JB
Citation: Chn. Veenhof et al., PHASE-II STUDY OF HIGH-DOSE MEGESTROL-ACETATE IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA, European journal of cancer, 30A(5), 1994, pp. 697-698
Authors:
DEBRUIJN HWA
TENHOOR KA
BOONSTRA H
MARRINK J
KRANS M
AALDERS JG
Citation: Hwa. Debruijn et al., CANCER-ASSOCIATED ANTIGEN CA-195 IN PATIENTS WITH MUCINOUS OVARIAN-TUMORS - A COMPARATIVE-ANALYSIS WITH CEA, TATI AND CA-125 IN SERUM SPECIMENS AND CYST FLUIDS, Tumor biology, 14(2), 1993, pp. 105-115
Authors:
PLUKKER JT
AALDERS JG
MENSINK HJA
OLDHOFF J
Citation: Jt. Plukker et al., TOTAL PELVIC EXENTERATION - A JUSTIFIED PROCEDURE, British Journal of Surgery, 80(12), 1993, pp. 1615-1617
Risultati:
1-12
|